Type 1 Diabetes Awareness Campaign - K1DS ARE HEROES - started
more
Stories about Genetik
Flu tests from R-Biopharm also detect new virus variants
moreStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
moreVectorBuilder Raised $57 Million for Gene Delivery R&D
moreVectorBuilder raised $57 million for gene delivery R&D
moreType 1 diabetes: New findings on the development of the autoimmune disease in children
more
Landscape of molecular contacts: How the coronavirus SARS-CoV-2 communicates with human cells
more- 2
Vitamin K prevents cell death: a new function for a long-known molecule
more R-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories
more- 2
R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist AusDiagnostics
more R-Biopharm announces test to detect monkeypox virus
moreInnovation and Start-Up Center for Biotechnology (IZB) welcomes new start-up Origin.Bio
One documentmore
- 2
R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation
more Microban® International Announces a New Range of Antiviral Technologies
more- 2
The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics
One documentmore New Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics
more- 2
COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant
One documentmore - 7
Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021
One documentmore
Gastrulation research reveals novel details about embryonic development
more- 2
Plant Protector: How plants strengthen their light-harvesting membranes against environmental stress
more Investment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M
moreDid my vaccine work? New rapid test for the determination of vaccination success
more- 2
Lindis Biotech develops immunotherapy against bladder cancer
One documentmore Origenis founds biotech company Neuron23 in Silicon Valley together with star investor Kleiner Perkins
One documentmore
- 4
ChromoTek and Absolute Antibody Collaborate on Recombinant Engineered Antibodies
One documentmore - 3
World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools
One documentmore - 5
Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups
One documentmore nal von minden plans to produce 80 million rapid corona tests per month
moreSwiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine
moreFollow your gut: How farms protect from childhood asthma
more
Previous123Next